Arcus Biosciences, Gilead shares are down after sharing data about new lung cancer drug

Shares of Arcus Biosciences Inc. RCUS, -27.76% were down 17.2% in premarket trading on Tuesday, the day after the company said the experimental treatment for metastatic non-small cell lung cancer that...

GILD Stock Hits 4-Year High After Notching Another Cancer Win; RCUS Stock Surges

Gilead Sciences (GILD) and Arcus Biosciences (RCUS) notched another win for their cancer program on Monday, briefly pushing GILD stock to a four-year high as RCUS stock gapped higher. X The companies ...